1.
Bioorg Med Chem Lett
; 18(3): 959-62, 2008 Feb 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-18182285
RESUMO
Novel 4-anilino-1H-pyrazolo[3,4-d]pyrimidines have been synthesized and evaluated in vitro for erbB2 and EGFR kinase inhibition. A representative compound displaying oral bioavailability in rat and dog illustrates the potential of this series to provide orally active erbB2 inhibitors.